North America Healthcare Exoskeletons Market by Application, Mobility Type, Product Function, Power Technology, and Country 2018-2023: Growth Opportunity and Business Strategy

  • Report ID : 100504
  • Category : IoT and Automation
  • Pages : 117
  • Reporting status : Published Jan, 19
Allows one Individual to access the Report within an organization
Allow Upto 5 User to access the Report within an organization
Allows all Employee to access the Report within an organization

Please choose the suitable license type from above.

Buy Now
  • Description
  • Table of Content
  • Research Methodology
  • Related Reports
GMD  predicts  the  North  America  healthcare  exoskeletons  market  will  reach  $401.89  million  in  2023  owing  to  a  growing  adoption  of  all  types  of  exoskeletons  in  North  America  healthcare  industry.

Highlighted  with  17  tables  and  45  figures,  this  117-page  report  “North  America  Healthcare  Exoskeletons  Market  by  Application,  Mobility  Type,  Product  Function,  Power  Technology,  and  Country  2018-2023:  Growth  Opportunity  and  Business  Strategy“  is  based  on  a  comprehensive  research  of  North  America  healthcare  exoskeletons  market  by  analyzing  the  entire  regional  market  and  all  its  sub-segments  through  extensively  detailed  classifications.  Profound  analysis  and  assessment  are  generated  from  premium  primary  and  secondary  information  sources  with  inputs  derived  from  industry  professionals  across  the  value  chain.  The  report  provides  historical  market  data  for  2014-2017,  revenue  estimates  for  2018,  and  forecasts  from  2019  till  2023.

In-depth  qualitative  analyses  include  identification  and  investigation  of  the  following  aspects:
•  Market  Structure  
•  Growth  Drivers  
•  Restraints  and  Challenges
•  Emerging  Product  Trends  &  Market  Opportunities
•  Porter’s  Fiver  Forces
The  trend  and  outlook  of  North  America  market  is  forecast  in  optimistic,  balanced,  and  conservative  view.  The  balanced  (most  likely)  projection  is  used  to  quantify  North  America  healthcare  exoskeletons  market  in  every  aspect  of  the  classification  from  perspectives  of  application,  mobility  type,  product  function,  power  technology  and  country.  
Based  on  application,  the  North  America  market  is  segmented  into  the  following  sections  with  annual  revenue  data  available  for  each  section  over  2014-2023:
•  Rehabilitation
•  Mobility  Aid  
•  Other  Applications  
On  basis  of  mobility  type,  the  North  America  market  is  studied  in  the  following  segments  with  annual  revenue  data  provided  for  each  sub-segment  covering  2014-2023:  
•  Mobile  Exoskeletons
•  Stationary  Exoskeletons
•  Tethered  Exoskeletons  
On  basis  of  product  function,  the  North  America  market  is  studied  in  the  following  segments  with  annual  revenue  available  for  each  sub-segment  covering  2014-2023:  
•  Upper  Body  Exoskeletons
•  Lower  Body  Exoskeletons
On  basis  of  power  technology,  the  North  America  market  is  segmented  into  the  following  sections  with  annual  revenue  forecast  for  each  section  covering  2014-2023:  
•  Active  Exoskeletons  (by  power  type,  this  section  is  further  classified  into  Electric  Actuator,  Pneumatic  Actuator,  Hydraulic  Actuator,  Fuel  Cell,  and  Others)
•  Passive  Exoskeletons  
Geographically,  the  following  national  markets  are  fully  investigated:
•  U.S.  
•  Canada
For  each  of  the  aforementioned  countries,  detailed  analysis  and  data  for  annual  revenue  are  available  for  2014-2023.  The  breakdown  of  all  national  markets  by  application  and  mobility  type  over  the  forecast  years  are  also  included.

The  report  also  includes  North  America  annual  shipment  2014-2023  based  on  direct  sales,  the  split  of  North  America  revenue  by  revenue  mode  over  the  forecast  years,  average  selling  price  of  healthcare  exoskeletons  for  2014-2023,  current  competitive  scenario  and  the  predicted  manufacture  trend,  and  profiles  12  healthcare  exoskeleton  vendors  including  market  leaders  and  important  emerging  players.

Specifically,  potential  risks  associated  with  investing  in  North  America  healthcare  exoskeletons  market  and  industry  are  assayed  quantitatively  and  qualitatively  through  GMD’s  Risk  Assessment  System.  According  to  the  risk  analysis  and  evaluation,  Critical  Success  Factors  (CSFs)  are  generated  as  a  guidance  to  help  investors  &  stockholders  identify  emerging  opportunities,  manage  and  minimize  the  risks,  develop  appropriate  business  models,  and  make  wise  strategies  and  decisions.

Companies  Mentioned
AlterG,  Inc.  
Bionik  Laboratories  Corp.  
Cyberdyne,  Inc.  
Ekso  Bionics  
Honda  Motor  Co.,  Ltd.  
Panasonic  Corporation  (Activelink)  
Parker  Hannifin  Corporation  
ReWalk  Robotics  Ltd.  
Rex  Bionics  Plc.  
U.S.  Bionics,  Inc.  (suitX)  

Want to customize this report?

We Can Customize The Report According To Your Need If Listed Report Does Not Meet Your Requirements,Our Research Will Cover All The Businesses Information Required By You.

Please Fill In The Customization Form With Your Requirements.

Help Center

Email Address :

Help Center

Toll Free :+442037693786

More FAQ's